These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28559332)

  • 1. Rifamycin action on RNA polymerase in antibiotic-tolerant
    Saito K; Warrier T; Somersan-Karakaya S; Kaminski L; Mi J; Jiang X; Park S; Shigyo K; Gold B; Roberts J; Weber E; Jacobs WR; Nathan CF
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4832-E4840. PubMed ID: 28559332
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening.
    Scharf NT; Molodtsov V; Kontos A; Murakami KS; Garcia GA
    SLAS Discov; 2017 Mar; 22(3):287-297. PubMed ID: 28027449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid].
    Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM
    Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico.
    Viader-Salvadó JM; Luna-Aguirre CM; Reyes-Ruiz JM; Valdez-Leal R; del Bosque-Moncayo Mde L; Tijerina-Menchaca R; Guerrero-Olazarán M
    Microb Drug Resist; 2003; 9(1):33-8. PubMed ID: 12705681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
    Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.
    Molodtsov V; Scharf NT; Stefan MA; Garcia GA; Murakami KS
    Mol Microbiol; 2017 Mar; 103(6):1034-1045. PubMed ID: 28009073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of codon 548 in the rpoB gene involved in Mycobacterium tuberculosis resistance to rifampin.
    Horng YT; Jeng WY; Chen YY; Liu CH; Dou HY; Lee JJ; Chang KC; Chien CC; Soo PC
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1542-8. PubMed ID: 25534743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
    Coll P; Aragón LM; Alcaide F; Espasa M; Garrigó M; González J; Manterola JM; Orús P; Salvadó M
    Microb Drug Resist; 2005; 11(2):107-14. PubMed ID: 15910223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population.
    Prakash R; Gupta R; Katoch VM; Tiwari PK
    J Infect Public Health; 2017; 10(5):593-599. PubMed ID: 28245964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
    ElMaraachli W; Slater M; Berrada ZL; Lin SY; Catanzaro A; Desmond E; Rodrigues C; Victor TC; Crudu V; Gler MT; Rodwell TC
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1222-6. PubMed ID: 26459537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.